New Drugs Drug News
ثبت نشده
چکیده
NEW DRUGS Generic Approvals Seasonale Contraceptive (Jolessa) Barr Laboratories has launched its generic version of Seasonale extendedcycle oral contraceptive under the trade name Jolessa. This launch followed the final approval by the U.S. Food and Drug Administration (FDA) of Watson Laboratories’ Abbreviated New Drug Application (ANDA) for Seasonale. Watson received approval following the expiration of the company’s three-year new product exclusivity on September 5, 2006. (Sources: Barr Pharmaceuticals, September 7, 2006; www.seasonique.com.)
منابع مشابه
New Drugs Drug News
NEW DRUGS Generic Desogestrel/Ethinyl Estradiol Contraceptives Watson Pharmaceuticals, Inc., has announced the final approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for desogestrel and ethinyl estradiol tablets USP, 0.15 mg/ 0.03 mg, a generic version of OrthoMcNeil’s Ortho-Cept® and Organon’s Desogen®. These products are indicated for th...
متن کاملNew Drugs Drug News
NEW DRUGS Generic Wellbutrin XL (Bupropion) for Depression The FDA has granted final approval of Impax Laboratories’ Abbreviated New Drug Application for a generic version of GlaxoSmithKline’s Wellbutrin XL 150 mg (bupropion extended-release tablets). An antidepressant, bupropion slows the absorption of dopamine and norepinephrine in the synapses between nerve cells. Source: Impax, November 28,...
متن کاملMaking connections: New Orleans Evacuees' experiences in obtaining drugs.
Between August 29 and September 7, 2005, almost all New Orleans residents were evacuated from the area in the aftermath of Hurricane Katrina. News reports indicate that almost 130,000 New Orleans Evacuees (NOEs) were evacuated to Houston, Texas, the largest recipient of the civilian population from New Orleans. Some of these NOEs were active participants in the illicit drug market in New Orlean...
متن کاملNEW DRUGS DRUG NEWS NEW DRUGS Rapid-Acting Clevidipine (Cleviprex) for Hypertension
NEW DRUGS Rapid-Acting Clevidipine (Cleviprex) for Hypertension The U.S. Food and Drug Administration (FDA) has approved the intravenous (IV) injectable emulsion clevidipine buty rate (Cleviprex, The Medicines Company) to reduce blood pressure when oral therapy is not feasible or desirable. A calcium-channel blocker, clevidi pine is metabolized in the blood and tissues and does not accumulate i...
متن کاملCancer treatments for the new millennium.
The SMR Symposium Cancer Treatments for the New Millennium was held on March 9, 2006, at the National Heart and Lung Institute, Imperial College London. The conference program brought together an international line-up of speakers representing academia, biotech and large pharma to discuss the development status of a number of new innovative treatments for the treatment or prevention of cancer. P...
متن کامل